Notably, the low UBE2C+ tumour cell score group exhibited a significantly elevated TMB compared to the high UBE2C+ tumour cell score group, with a statistically significant distinction (p < 0.01) between the two cohorts (Figure S5D). This evidence concerns the gene UBE2C and neoplasm.